Cargando…
Homotypic Cell Membrane-Cloaked Biomimetic Nanocarrier for the Targeted Chemotherapy of Hepatocellular Carcinoma
Goals: Hepatocellular carcinoma (HCC) has been reported to be the third most common malignant tumor and has the highest rate of mortality. To increase the chemotherapy efficacy of HCC, a drug delivery system featured with desirable active targeting ability, delivery efficiency and immune evasion is...
Autores principales: | Liu, Xiaojun, Sun, Yingxue, Xu, Shushen, Gao, Xiaonan, Kong, Fanpeng, Xu, Kehua, Tang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6735366/ https://www.ncbi.nlm.nih.gov/pubmed/31534522 http://dx.doi.org/10.7150/thno.34837 |
Ejemplares similares
-
Homotypic cell membrane-cloaked biomimetic nanocarrier for the accurate photothermal-chemotherapy treatment of recurrent hepatocellular carcinoma
por: Sun, Yingxue, et al.
Publicado: (2020) -
Targeted delivery of fat extract by platelet membrane-cloaked nanocarriers for the treatment of ischemic stroke
por: Wang, Cheng, et al.
Publicado: (2022) -
Double-ratiometric fluorescence imaging of H(2)Se and O(2)˙(−) under hypoxia for exploring Na(2)SeO(3)-induced HepG2 cells' apoptosis
por: Gao, Xiaonan, et al.
Publicado: (2018) -
Safe and Immunocompatible Nanocarriers Cloaked in RBC Membranes for Drug Delivery to Treat Solid Tumors
por: Luk, Brian T., et al.
Publicado: (2016) -
A highly selective near-infrared fluorescent probe for imaging H(2)Se in living cells and in vivo
por: Kong, Fanpeng, et al.
Publicado: (2016)